Content about Collaborative Care

ALEXANDRIA, Va. — Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.

SILVER SPRING, Md. — Sunpeaks Ventures last week announced national advertising support behind its Clotamin multivitamin line — a line of supplements formulated for use by patients on warfarin or other blood thinners.

"Until now, Clotamin has never been the focus of any consumer marketing," stated Mackie Barch, Sunpeaks CEO. "The product's popularity has been built solely through positive word of mouth from our customers and through pharmacies that already carry the product."

NEW YORK — Walgreens and Duane Reade stores are facing off on a challenge regarding which banner can raise the most funds over a four-week period in the fall in support of the American Diabetes Association Greater New York City Area, the ADA announced Monday.

Duane Reade will conduct the campaign in October and Walgreens will conduct the campaign in November.

WASHINGTON — The Consumer Healthcare Products Association and the other members of the Health Choices Coalition on Friday sent letters to members of Congress urging the repeal of the requirement that prevents consumers from using their flexible spending arrangements to purchase over-the-counter medicines without first getting a doctor’s prescription. 

CHATSWORTH, Calif. — Natrol on Thursday announced the launch of a new line of supplements that will ship later this year.

SALT LAKE CITY — Schiff has realized some sales success reducing its reliance on promotion across the joint health category — a category that has been defined by the prevalence of buy-one, get-one deals over the past few years — the company told analysts Thursday in a discussion on fiscal 2012 third-quarter results.

MINNETONKA, Minn. — Supervalu banner Shop 'n Save Pharmacy has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance.

WASHINGTON — People with diabetes are at increased risk of hearing loss, which has prompted two groups to encourage those living with the disease to have their hearing checked.

The American Diabetes Association and the Better Hearing Institute are launching the effort as part of the ADA's Diabetes Alert Day, on Tuesday, which also includes an effort to encourage people to check if they are at risk of developing Type 2 diabetes.

SILVER SPRING, Md. — GlaxoSmithKline on Thursday morning presented exactly how technology might improve appropriate patient self-selection before a panel convened by the Food and Drug Administration to explore expanding the prescripton-to-over-the-counter switch paradigm by incorporating technology and/or pharmacy participation in the application process.

CAMP HILL, Pa. — Rite Aid is sponsoring skin cancer screenings at dozens of stores across the country as part of a tour that begins this month and ends in August, the retail pharmacy chain said Thursday.

Rite Aid said the Skin Cancer Foundation would travel across the country in a 38-ft. RV to more than 50 Rite Aid locations as part of the Road to Healthy Skin Tour, which Aveeno also is co-sponsoring, starting this week.

Teva Pharmaceutical Industries Ltd. announced on March 14 that it has commenced commercial launch of escitalopram oxalate tablets, the company’s generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment Lexapro tablets.

The branded product had annual sales of approximately $2.9 billion in the United States, based on IMS sales data. As the first company to file an abbreviated new drug application containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity.